An Efficient Bioconjugation Technology for Site-Selective Covalent Modification of Antibodies using an Engineered Affinity Peptide
Exclusively Licensed
Invention type: Technology
/
Case number: #25358
Researchers
Bradley L. Pentelute
/
Katsushi Kitahara
/
Aurelie Rondon
/
Heemal Dhanjee
/
Jacob Rodriguez
/
Andrei Loas
Departments: Department of Chemistry
Technology Areas: Biotechnology: Synthetic Biology / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
site-selective conjugation of a pharmaceutical agent to an antibody using an affinity peptide
Patent Cooperation Treaty | Published application -
site-selective conjugation of a pharmaceutical agent to an antibody using an affinity peptide
United States of America | Published application
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.